JP2020516313A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020516313A5 JP2020516313A5 JP2020504441A JP2020504441A JP2020516313A5 JP 2020516313 A5 JP2020516313 A5 JP 2020516313A5 JP 2020504441 A JP2020504441 A JP 2020504441A JP 2020504441 A JP2020504441 A JP 2020504441A JP 2020516313 A5 JP2020516313 A5 JP 2020516313A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- peptide
- cancer
- cell receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762483690P | 2017-04-10 | 2017-04-10 | |
| DE102017107710.3 | 2017-04-10 | ||
| DE102017107710 | 2017-04-10 | ||
| US62/483,690 | 2017-04-10 | ||
| PCT/EP2018/059114 WO2018189152A2 (en) | 2017-04-10 | 2018-04-10 | Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020516313A JP2020516313A (ja) | 2020-06-11 |
| JP2020516313A5 true JP2020516313A5 (https=) | 2021-08-05 |
| JP7026970B2 JP7026970B2 (ja) | 2022-03-01 |
Family
ID=62116820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020504441A Expired - Fee Related JP7026970B2 (ja) | 2017-04-10 | 2018-04-10 | 白血病およびその他のがんに対する免疫療法において使用するためのペプチドおよびペプチドの組み合わせ |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20220118016A1 (https=) |
| EP (1) | EP3609531A2 (https=) |
| JP (1) | JP7026970B2 (https=) |
| KR (1) | KR20190137858A (https=) |
| CN (3) | CN112521478A (https=) |
| AU (1) | AU2018253341B2 (https=) |
| BR (1) | BR112019021094A2 (https=) |
| CA (1) | CA3059645A1 (https=) |
| CL (7) | CL2019002878A1 (https=) |
| CO (1) | CO2019012071A2 (https=) |
| CR (1) | CR20190509A (https=) |
| IL (1) | IL269813A (https=) |
| MA (1) | MA49123A (https=) |
| MX (1) | MX2019012226A (https=) |
| MY (1) | MY197772A (https=) |
| PE (1) | PE20191617A1 (https=) |
| PH (1) | PH12019502300A1 (https=) |
| SG (3) | SG11201909058WA (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106061488B (zh) * | 2013-12-02 | 2021-04-09 | 菲奥医药公司 | 癌症的免疫治疗 |
| BR112019015355A2 (pt) * | 2017-01-26 | 2020-05-19 | Sangamo Therapeutics Inc | modificação genética de células b |
| MX2019015879A (es) * | 2017-07-07 | 2020-02-07 | Immatics Biotechnologies Gmbh | Nuevos peptidos y nuevas combinacones de peptidos para el uso en la inmunoterapia contra el cancer de pulmon, incluyendo el nsclc, el sclc y otros canceres. |
| CN113109564A (zh) * | 2021-03-15 | 2021-07-13 | 成都益安博生物技术有限公司 | 一种急性髓细胞性白血病的外周血tcr标志物及其检测试剂盒和应用 |
| CN117586344B (zh) * | 2022-08-12 | 2025-07-25 | 上海交通大学医学院附属瑞金医院 | 靶向flt3-d835突变的抗原肽及其在肿瘤免疫治疗中的应用 |
| CN117552115B (zh) * | 2024-01-12 | 2024-03-26 | 天津鲸鹏生物科技有限责任公司 | 用于诱导肿瘤特异性免疫响应的通用型抗原肽库及其应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040005561A1 (en) * | 2000-03-01 | 2004-01-08 | Corixa Corporation | Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| US20030148321A1 (en) | 2001-08-24 | 2003-08-07 | Iris Pecker | Methods and kits for diagnosing and monitoring hematopoietic cancers |
| US8039218B2 (en) | 2002-11-14 | 2011-10-18 | John Wayne Cancer Institute | Detection of cancer cells in body fluids |
| WO2004106511A1 (ja) | 2003-05-30 | 2004-12-09 | Nippon Shinyaku Co., Ltd. | Ｂｃｌ−２の発現抑制をするオリゴ二本鎖ＲＮＡとそれを含有する医薬組成物 |
| EP1872124A4 (en) | 2005-04-19 | 2008-06-11 | Prediction Sciences Llc | DIAGNOSIS MARKET FOR BREAST CANCER TREATMENT AND PROGRESSION AND METHOD OF USE THEREOF |
| WO2007011856A2 (en) | 2005-07-15 | 2007-01-25 | The Trustees Of Columbia University In The City Of New York | Compositions and methods for differential diagnosis of chronic lymphocytic leukemia |
| SI1806358T1 (sl) | 2005-09-05 | 2010-06-30 | Immatics Biotechnologies Gmbh | S tumorjem povezani peptidi ki se promiskuitetnovežejo na molekule humanega levkocitnega antigena HLA razreda II |
| WO2007064743A2 (en) * | 2005-11-30 | 2007-06-07 | Cell Signaling Technology, Inc. | Reagents for the detection of protein phosphorylation in leukemia signaling pathways |
| WO2008103905A2 (en) | 2007-02-23 | 2008-08-28 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Antibodies that specifically bind irta and methods of use |
| HUE032379T2 (en) * | 2007-07-27 | 2017-09-28 | Immatics Biotechnologies Gmbh | Composition of tumour-associated peptides and related anti-cancer vaccine |
| GB0721686D0 (en) * | 2007-11-05 | 2007-12-12 | Medinnova As | Polypeptides |
| WO2010019921A2 (en) | 2008-08-15 | 2010-02-18 | The Regents Of The University Of California | Biomarkers for diagnosis and treatment of chronic lymphocytic leukemia |
| US20120077696A1 (en) | 2009-03-15 | 2012-03-29 | Technion Research And Development Foundation Ltd. | Soluble hla complexes for use in disease diagnosis |
| US20120178111A1 (en) | 2009-09-23 | 2012-07-12 | Diamandis Eleftherios P | Methods and compositions for the detection of lung cancers |
| WO2014180490A1 (en) | 2013-05-10 | 2014-11-13 | Biontech Ag | Predicting immunogenicity of t cell epitopes |
| TWI636065B (zh) * | 2013-08-05 | 2018-09-21 | 伊瑪提克斯生物科技有限公司 | 新穎肽類，細胞及其用於治療多種腫瘤的用途，其製造方法及包含其等之醫藥組成物 |
| GB201319446D0 (en) | 2013-11-04 | 2013-12-18 | Immatics Biotechnologies Gmbh | Personalized immunotherapy against several neuronal and brain tumors |
| GB201408255D0 (en) | 2014-05-09 | 2014-06-25 | Immatics Biotechnologies Gmbh | Novel immunotherapy against several tumours of the blood, such as acute myeloid leukemia (AML) |
| GB201411037D0 (en) | 2014-06-20 | 2014-08-06 | Immatics Biotechnologies Gmbh | Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemai (CLL) |
| GB201507030D0 (en) | 2015-04-24 | 2015-06-10 | Immatics Biotechnologies Gmbh | Immunotherapy against lung cancers, in particular NSCLC |
| GB201511191D0 (en) | 2015-06-25 | 2015-08-12 | Immatics Biotechnologies Gmbh | T-cell epitopes for the immunotherapy of myeloma |
| GB201515321D0 (en) | 2015-08-28 | 2015-10-14 | Immatics Biotechnologies Gmbh | Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers |
| GB201521746D0 (en) | 2015-12-10 | 2016-01-27 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers |
| GB201521894D0 (en) | 2015-12-11 | 2016-01-27 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against various cancers |
-
2018
- 2018-04-10 SG SG11201909058W patent/SG11201909058WA/en unknown
- 2018-04-10 BR BR112019021094-6A patent/BR112019021094A2/pt not_active IP Right Cessation
- 2018-04-10 MA MA049123A patent/MA49123A/fr unknown
- 2018-04-10 SG SG10202100324YA patent/SG10202100324YA/en unknown
- 2018-04-10 JP JP2020504441A patent/JP7026970B2/ja not_active Expired - Fee Related
- 2018-04-10 PE PE2019001977A patent/PE20191617A1/es unknown
- 2018-04-10 KR KR1020197032832A patent/KR20190137858A/ko not_active Withdrawn
- 2018-04-10 CN CN202011264405.8A patent/CN112521478A/zh active Pending
- 2018-04-10 AU AU2018253341A patent/AU2018253341B2/en not_active Ceased
- 2018-04-10 CN CN202010276749.4A patent/CN111533799A/zh active Pending
- 2018-04-10 CA CA3059645A patent/CA3059645A1/en active Pending
- 2018-04-10 SG SG10202100326SA patent/SG10202100326SA/en unknown
- 2018-04-10 CR CR20190509A patent/CR20190509A/es unknown
- 2018-04-10 EP EP18722907.5A patent/EP3609531A2/en not_active Withdrawn
- 2018-04-10 MX MX2019012226A patent/MX2019012226A/es unknown
- 2018-04-10 CN CN201880023853.3A patent/CN110944660A/zh active Pending
- 2018-04-10 MY MYPI2019005841A patent/MY197772A/en unknown
-
2019
- 2019-10-03 IL IL26981319A patent/IL269813A/en unknown
- 2019-10-07 PH PH12019502300A patent/PH12019502300A1/en unknown
- 2019-10-09 CL CL2019002878A patent/CL2019002878A1/es unknown
- 2019-10-29 CO CONC2019/0012071A patent/CO2019012071A2/es unknown
-
2020
- 2020-11-13 CL CL2020002948A patent/CL2020002948A1/es unknown
- 2020-11-13 CL CL2020002949A patent/CL2020002949A1/es unknown
- 2020-11-13 CL CL2020002952A patent/CL2020002952A1/es unknown
- 2020-11-13 CL CL2020002951A patent/CL2020002951A1/es unknown
- 2020-11-13 CL CL2020002953A patent/CL2020002953A1/es unknown
- 2020-11-13 CL CL2020002950A patent/CL2020002950A1/es unknown
-
2021
- 2021-06-23 US US17/356,174 patent/US20220118016A1/en not_active Abandoned
-
2022
- 2022-06-17 US US17/843,412 patent/US11559550B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020516313A5 (https=) | ||
| JP7542870B2 (ja) | 免疫療法のためのナノ粒子組成物及び方法 | |
| JP2020191862A5 (https=) | ||
| JP2019515650A5 (https=) | ||
| JP2020198875A5 (https=) | ||
| JP2020516681A5 (https=) | ||
| JP2019536426A5 (https=) | ||
| HRP20202019T1 (hr) | Novi peptidi i kombinacija peptida za uporabu u imunoterapiji protiv raka jajnika i drugih malignih tumora | |
| JP2019513005A5 (https=) | ||
| JP2020506690A5 (https=) | ||
| JP2021532818A5 (https=) | ||
| JP2019515653A5 (https=) | ||
| JP2019520038A5 (https=) | ||
| ME03808B (me) | Novi peptidi i kombinacija peptida za upotrebu u imunoterapiji za epitelijalni karcinom jajnika i druge maligne tumore | |
| CN112654346B (zh) | 生物分子包覆颗粒和薄膜及其用途 | |
| ME02692B (me) | NOVA IMUNOTERAPIJA PROTIV NEKOLIKO TUMORA UKLJUČUJUĆI GASTROINTESTINALNI KARCINOM l KARCINOM ŽELUCA | |
| JP2021535900A5 (https=) | ||
| JP2022554395A5 (https=) | ||
| JP2021528046A5 (https=) | ||
| JP2016530224A (ja) | 免疫療法のための組成物及び方法 | |
| HRP20230878T1 (hr) | Novi peptidi i kombinacija peptida za uporabu u imunoterapiji protiv raznih karcinoma (seq id 25 - mrax5-003) | |
| JP2022502015A5 (https=) | ||
| JP2022502358A5 (https=) | ||
| JP2021522779A5 (https=) | ||
| JP2020191868A5 (https=) |